Cagrilintide 5mg+
Higher-strength cagrilintide presentation for advanced research dosing.
How it works
Same amylin/calcitonin agonism as standard cagrilintide, supplied at a higher mg/vial concentration to support multi-week research protocols.
Reported benefits
- See Cagrilintide entry for clinical data
Dosage & administration
Reconstitute to deliver the same per-dose volumes as the standard 5 mg presentation.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- Identical to base cagrilintide
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
10 mg
CS10
Box of 10 · $501
Single vial · $1,002
Related guides
Tirzepatide
A first-in-class dual GIP and GLP-1 receptor agonist that has reset the standard for pharmacologic weight loss.
Semaglutide
The long-acting GLP-1 analogue that opened the modern era of injectable weight management.
Retatrutide
An investigational triple agonist of GLP-1, GIP, and glucagon receptors producing unprecedented weight loss in phase-2 data.